Friday, July 10, 2026

Drug profile · INN

birch triterpenes

birch triterpenes (FILSUVEZ) is a unknown. Route of administration: topical. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 1
Pipeline programs 0
News articles 0
Drug details — birch triterpenes
US status
approved
Class
Route
TOPICAL
Patents
1
Programs
0
Data quality
0.84

Quick answer

birch triterpenes (FILSUVEZ) is a unknown. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN birch triterpenes
Brand FILSUVEZ
Mechanism Unknown
Route TOPICAL
Formulation GEL

Mechanism of action

Unknown

Approval history

Authority Status Date
FDA approved

Related patents

  1. US 12268695

    Betulin-containing birch bark extracts and their formulation

    Expires Mon Apr 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is birch triterpenes?

birch triterpenes (FILSUVEZ) is a unknown. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for birch triterpenes?

FILSUVEZ is a marketed brand name for birch triterpenes. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of birch triterpenes?

birch triterpenes has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.